Posted on 19th March 202119th March 2021 by Bernardo Cortese Posted in Scientific Publications Leave a comment Reply letter to Piccoleto II : seeking an appropriate primary endpoint for DCB clinical trials Reply Letter to PII DCB, Piccoleto II, PII 19th March 2021 in Scientific PublicationsAngioplastica coronarica: i benefici del pallone medicato19th March 2021 in Scientific PublicationsDCB ROUNDTABLE19th March 2021 in Scientific PublicationsIs Paclitaxel-Eluting Stent Use Justified by an Adequate Risk Profile?19th March 2021 in Scientific PublicationsFocus on Drug coated balloons – Summeet Webinar19th March 2021 in Scientific PublicationsSeQuent Please NEO “DCB ONLY APPROACH”: publish or Up-To-Date Scientific Data – B.Braun 2020 Webinar19th March 2021 in Scientific PublicationsDCB in de novo lesions – CardioAlex 20 Webinar19th March 2021 in Scientific PublicationsWEBINAR: Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel19th March 2021 in Scientific PublicationsEASTBOURNE registry finished the enrollment19th March 2021 in Scientific PublicationsDCB clinical data and the role of scoring balloon in preparing the lesion-Webinar during GISE 2020 Leave a comment Cancel replyYou must be logged in to post a comment.